Gilead COVID-19 drug gets expanded WHO recommendation

0
10

Gilead Sciences Inc. GILD, -0.28% said late Thursday the World Health Organization expanded its recommended guide for the use of the biotech drug maker’s COVID-19 treatment Veklury. In a statement, the company said WHO updated its guidelines to recommend the drug to treat patients with severe COVID, an expansion from simply “those with non-severe COVID-19 at the highest risk of hospitalization.” In late July, European Commission regulators recommended that Veklury be used as an expanded COVID-19 treatment. Veklury

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleEarnings Results: Who doesn’t love bowling? Shares of Bowlero jump after hours as sales beat estimates.
Next articleU.S. stocks finish lower for second time in three days as Treasury yields climb

LEAVE A REPLY

Please enter your comment!
Please enter your name here